--2025/Q1-- / 13.466B--
--2024/Q4-- / 13.995B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 753.410
- +23.680+3.25%
Close Nov 20 16:00 ET
- 751.705
- -1.705-0.23%
Pre 08:39 ET
715.22BMarket Cap81.45P/E (TTM)
757.370High735.460Low5.16MVolume735.785Open729.730Pre Close3.87BTurnover0.55%Turnover Ratio129.90P/E (Static)949.32MShares970.91652wk High50.23P/B713.67BFloat Cap557.99452wk Low5.03Dividend TTM947.25MShs Float970.916Historical High0.67%Div YieldTTM3.00%Amplitude5.278Historical Low749.547Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q3 2024 Earnings Date
Overview | Q3 net profit of $0.97 billion, sales of major diet pills fell short of expectations, and full-year revenue guidance was lowered
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 12.12B | 11.44B | -679.50M |
| Miss Est. | +27.58% | +20.43% | -5.61% |
| EPS | 1.54 | 1.07 | -0.47 |
| Miss Est. | +2677.80% | +1883.33% | -30.70% |
Analyst Rating
Nov 18, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
